Eagle Pharmaceuticals Announces Results Of Study Conducted In Partnership US Military To Evaluate Neuroprotective Effects Of RYANODEX For Treatment Of Nerve Agent Exposure; Results Showed Statistically Significant Lower Incidence Of Brain Damage Compared
Benzinga Newsdesk